Stay updated on Ruxolitinib for Eosinophilic Disorders Clinical Trial

Sign up to get notified when there's something new on the Ruxolitinib for Eosinophilic Disorders Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ruxolitinib for Eosinophilic Disorders Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page shows a revision tag updated from v3.5.2 to v3.5.3, indicating a platform version update. No study details, eligibility criteria, or results text appear to be altered.
    Difference
    0.1%
    Check dated 2026-04-30T15:45:21.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    - Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T10:51:50.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T18:04:31.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-11T15:23:34.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the prior v3.4.1 notice removed, indicating an administrative update. No core content or study details were changed; to avoid alerts for minor updates, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:19:53.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    A site-wide government funding/status notice was added and the page shows Revision: v3.4.1, replacing the previous v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T00:55:39.000Z thumbnail image

Stay in the know with updates to Ruxolitinib for Eosinophilic Disorders Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ruxolitinib for Eosinophilic Disorders Clinical Trial page.